Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy

BACKGROUND: Adults with cerebral palsy (CP) have an increased risk for polypharmacy, premature mortality, and early development of several morbidities, including conditions associated with excess medication exposure, such as chronic kidney disease (CKD) and liver disease. To date, very little is kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitney, Daniel G, Schmidt, Mary, Haapala, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391225/
https://www.ncbi.nlm.nih.gov/pubmed/33377441
http://dx.doi.org/10.18553/jmcp.2021.27.1.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391225/
https://www.ncbi.nlm.nih.gov/pubmed/33377441
http://dx.doi.org/10.18553/jmcp.2021.27.1.051

Ejemplares similares